Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of Psilocybin… Nov 3, 2021
PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease Oct 6, 2021
